Sentence examples for maker of brands from inspiring English sources

What might seem like an admission of the obvious is also a profound about-face for the maker of brands such as Marlboro.

Three years ago, after leaving a marketing job at the Brown & Williamson Tobacco Corporation, the maker of brands like Kool and Viceroy, Patrick Carroll embarked on a quest to create a boutique alternative to Big Tobacco's mass-produced cigarettes.

The stagnant eurozone economy and a slowdown in China and other emerging markets have suppressed sales for the maker of brands including Dove soap, Vienetta ice cream and Lynx deodorant.

How? "It's clear to say that introducing a new product in a restrictive marketing environment is quite a challenge," said Susan Ivey, who has been president since January of Brown & Williamson, the maker of brands like Kool and Lucky Strike.

Last month, Tesco became embroiled in a row with the supplier Unilever after the maker of brands including Marmite and Persil demanded an across-the-board 10% rise in prices in light of the devaluation of the pound.

This week Unilever, maker of brands from Marmite to Magnum and the world's second-biggest advertiser, threatened to withdraw its advertising from Facebook and YouTube unless they cleaned up the "swamp" of opaque business practices and dodgy content.

Larry O'Connor, the founder and president of Other World Computing, a maker of brand of solid-state drives.

But a maker of brand-name drugs can often win a 30-month delay in federal approval of generic drugs by claiming patent infringement.

The auction is riveting drug makers and analysts because it pits the world's biggest maker of brand-name drugs, the American company Pfizer, against the global leader in generics, Teva Pharmaceutical Industries, with headquarters in Israel.

While the drug company in Mr. le Carré's novel was depicted as a European maker of brand-name drugs, the pharmaceutical company that was really doing battle with Dr. Olivieri was Apotex, a leading maker of generic drugs.

Under current law, a maker of brand-name drugs can often get a 30-month delay in federal approval of generic drugs by filing a lawsuit that alleges infringement of its patents.